News & Updates

Adding azithromycin to standard care yields no survival benefit in ambulatory managed COVID-19

24 Aug 2021 by

The addition of azithromycin to standard care did not reduce hospitalization or mortality risk in patients with mild-to-moderate COVID-19 who underwent ambulatory management, according to results of the ATOMIC2 trial presented at ECCMID 2021.

Adding azithromycin to standard care yields no survival benefit in ambulatory managed COVID-19

24 Aug 2021

Tislelizumab-chemo a suitable first-line treatment alternative for advanced sq-NSCLC?

23 Aug 2021 by

The addition of the monoclonal antibody tislelizumab to chemotherapy (CT) offers superior clinical benefit over CT alone as reflected by the prolonged progression-free survival (PFS), higher objective response rate (ORR), and a manageable safety and tolerability profile, underlining the potential of the combo regimen as a first-line treatment alternative for individuals with advanced squamous non-small-cell lung cancer (sq-NSCLC), the RATIONALE 307 trial suggests.

Tislelizumab-chemo a suitable first-line treatment alternative for advanced sq-NSCLC?

23 Aug 2021

Azithromycin confers no effect on bronchial wall thickness, increases lumen area, radius

21 Aug 2021

In patients with severe persistent asthma, treatment with azithromycin helps increase the bronchial lumen radius and lumen area, as shown in a study. However, it appears to have no significant effect on wall thickness.

Azithromycin confers no effect on bronchial wall thickness, increases lumen area, radius

21 Aug 2021

Pulmonary function foretells chronic heart failure outcome

20 Aug 2021

Forced expiratory volume in one second is predictive of progression of chronic heart failure, according to data from the MyoVasc study.

Pulmonary function foretells chronic heart failure outcome

20 Aug 2021

Ultrasound may help screen for interstitial lung disease in HIV-positive patients

19 Aug 2021

Ultrasound appears to provide a fast, reliable, and sensitive point-of-care tool for detecting interstitial lung disease among HIV-positive patients, according to a study. However, ultrasound falls short of differentiating between different disease aetiologies.

Ultrasound may help screen for interstitial lung disease in HIV-positive patients

19 Aug 2021

Birthday celebrations may up household COVID-19 transmission risk in high prevalence areas

17 Aug 2021 by

Informal social gatherings such as birthdays may be associated with an increased risk of household COVID-19 transmission in areas with high COVID-19 prevalence, according to a cross-sectional study conducted in the US.

Birthday celebrations may up household COVID-19 transmission risk in high prevalence areas

17 Aug 2021

Effective therapeutic options needed for M abscessus pulmonary disease, study says

17 Aug 2021 by

A multidrug regimen containing inhaled amikacin with or without clofazimine improves outcomes in patients with pulmonary disease (PD) caused by Mycobacterium abscessus subspecies massiliense, according to a study. However, the regimen shows only moderate efficacy in treating infections with the abscessus subspecies.

Effective therapeutic options needed for M abscessus pulmonary disease, study says

17 Aug 2021

Bedaquiline-pretomanid-linezolid combo tackles highly drug-resistant TB

16 Aug 2021 by

The combined regimen of bedaquiline, pretomanid, and linezolid (BPaL) may help treat highly drug-resistant tuberculosis (TB), even with lower doses or shorter treatment duration of linezolid, according to results of the phase III ZeNix trial presented at IAS 2021.

Bedaquiline-pretomanid-linezolid combo tackles highly drug-resistant TB

16 Aug 2021

Frequent energy drink consumption ups risk of asthma, allergic rhinitis, atopic dermatitis

14 Aug 2021

People who regularly consume energy drinks are at heightened risk of developing allergic diseases, including asthma, allergic rhinitis (AR), and atopic dermatitis (AD), according to a study in Korea.

Frequent energy drink consumption ups risk of asthma, allergic rhinitis, atopic dermatitis

14 Aug 2021

Pulmonary hypertension linked to poor outcomes in COPD

13 Aug 2021

Chronic obstructive pulmonary disorder (COPD) patients with pulmonary hypertension appear to have greater functional impairment and poorer outcomes relative to those with idiopathic pulmonary arterial hypertension, a study has found.

Pulmonary hypertension linked to poor outcomes in COPD

13 Aug 2021

News & Updates

Filter by Specialty:

Specialty:

Adding azithromycin to standard care yields no survival benefit in ambulatory managed COVID-19

Adding azithromycin to standard care yields no survival benefit in ambulatory managed COVID-19

Tislelizumab-chemo a suitable first-line treatment alternative for advanced sq-NSCLC?

Tislelizumab-chemo a suitable first-line treatment alternative for advanced sq-NSCLC?

Azithromycin confers no effect on bronchial wall thickness, increases lumen area, radius

Azithromycin confers no effect on bronchial wall thickness, increases lumen area, radius

Pulmonary function foretells chronic heart failure outcome

Pulmonary function foretells chronic heart failure outcome

Ultrasound may help screen for interstitial lung disease in HIV-positive patients

Ultrasound may help screen for interstitial lung disease in HIV-positive patients

Birthday celebrations may up household COVID-19 transmission risk in high prevalence areas

Birthday celebrations may up household COVID-19 transmission risk in high prevalence areas

Effective therapeutic options needed for M abscessus pulmonary disease, study says

Effective therapeutic options needed for M abscessus pulmonary disease, study says

Bedaquiline-pretomanid-linezolid combo tackles highly drug-resistant TB

Bedaquiline-pretomanid-linezolid combo tackles highly drug-resistant TB

Frequent energy drink consumption ups risk of asthma, allergic rhinitis, atopic dermatitis

Frequent energy drink consumption ups risk of asthma, allergic rhinitis, atopic dermatitis

Pulmonary hypertension linked to poor outcomes in COPD

Pulmonary hypertension linked to poor outcomes in COPD